Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

ClinicalTrials.gov ID: NCT02834793

Public ClinicalTrials.gov record NCT02834793. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to demonstrate that perampanel given as adjunctive anti-epileptic treatment is superior to placebo in reducing the number of drop seizures in participants with inadequately controlled seizures associated with Lennox-Gastaut Syndrome (LGS).

Study identification

NCT ID
NCT02834793
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
101 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 13, 2016 (Actual)
Primary completion
May 26, 2021 (Actual)
Completion
Jul 19, 2021 (Actual)
Last update posted
Mar 9, 2022

2016 – 2021

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72202-3500 —
Stanford University Palo Alto California 94304 —
Northwest Florida Clinical Research Group, LLC Gulf Breeze Florida 32561 —
University of Florida Jacksonville Jacksonville Florida 32209 —
Pediatric Neurologists of Palm Beach Loxahatchee Groves Florida 33470 —
Axcess Medical Research Loxahatchee Groves Florida — —
Nicklaus Children's Hospital Miami Florida 33155 —
Pediatric Neurology PA Orlando Florida 32819 —
Children's Healthcare of Atlanta Atlanta Georgia 30342 —
Consultants In Epilepsy and Neurology PLLC Boise Idaho 83702 —
Carle Foundation Hospital Urbana Illinois 61801 —
Midatlantic Epilepsy and Sleep Center Bethesda Maryland 20817 —
Children's Hospital of Michigan Detroit Michigan 48201 —
Wayne State University Detroit Michigan 48201 —
Mercy Health Saint Mary's Campus Grand Rapids Michigan 49301 —
Minnesota Epilepsy Group PA Saint Paul Minnesota 55102 —
Children's Mercy Hospital Kansas City Missouri 64108 —
Children's Hospital at Saint Peter's University Hospital New Brunswick New Jersey 08901 —
Cincinnati Children's Hospital Medical Center - PIN Cincinnati Ohio 45229 —
Cleveland Clinic Cleveland Ohio 44195 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
The University of Pittsburgh Pittsburgh Pennsylvania 15213 —
Austin Epilepsy Care Center Austin Texas 78758 —
Road Runner Research Ltd San Antonio Texas 78249 —
Baylor Scott and White Research Institute Temple Texas 76508 —
Clinical Neurosciences Center Salt Lake City Utah 84132 —
Virginia Commonwealth University Richmond Virginia 23298 —
MultiCare Institute for Research and Innovation Tacoma Washington 98405 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —
Columbia Saint Mary's Milwaukee Wisconsin 53211 —
Medical College of Wisconsin Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02834793, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2022 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02834793 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →